Funded Tech Companies
Aerovate Therapeutics
Headquartered in Boston, Aerovate Therapeutics has funding from Atlas Venture, Osage Partners and Sofinnova Ventures.
Company Overview
Company Name
Aerovate Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
200 Berkeley St. 18th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Company Background Information
Overview
Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's lead program is a potentially disease modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/17/2022
Financing History
Management Team
Title
Name
Email & Social
Chief Medical Officer
Hunter Gillies
President
Benjamin Dake
VP - Bus. Development
Ralph Niven
Company Investors
- Atlas Venture
- Osage Partners
- Sofinnova Ventures (Maha Katabi)
- Cormorant Asset Management
- Surveyor Capital
Browse more funded tech companies:
AeroVanti Air Club | AerovectRx
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs